Morgan Stanley (NYSE:MS) analyst Lauren Cassel maintained a Hold rating on GoHealth on Friday, setting a price target of $14, which is approximately 21.11% above the present share price of $11.56.
Cassel expects GoHealth to post earnings per share (EPS) of $0.43 for the second quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Strong Buy rating of shares in GoHealth, with an average price target of $17.
The analysts price targets range from a high of $20 to a low of $14.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $445.92 million and a net profit of $141.83 million. The company's market cap is $3.64 billion.
According to TipRanks.com, Morgan Stanley analyst Lauren Cassel is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -12.9% and a 68.42% success rate.
GoHealth Inc is a health insurance marketplace in America. Its technology platform leverages modern machine-learning algorithms and helps individuals find the best health insurance plan for their specific needs. The company operates in four segments: Medicare-Internal; Medicare-External, IFP and Other-Internal; and IFP and Other-External. The Medicare segments sales Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans.